series-b
Stage
2018
Founded
1
Investors
About
Taysha GTx develops gene therapies targeting monogenic diseases of the central nervous system, with a current focus on treatments for Rett syndrome.
Explore Taysha GTx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.